Received: 25 February 2021
Accepted: 22 November 2021
First Online: 16 December 2021
: Ethical approval for the implementation of the digital solution as a quality improvement project was sought through the local West London CCG Information Governance body (not an official ethics committee) as well as passing information governance requirements set out by NHS-X (an official ethics/IG panel). This process was carried out by completing the NHS’s Digital Assessment Questionnaire process which allowed this pilot to proceed. This research was carried out as a measure of effectiveness of this already implemented solution.Informed consent (e-consent) was obtained digitally in the form of a digital signature of which a copy was emailed to participants. Participants had the option to use the app as part of their clinical care as well as allowing their anonymised (non-PI) data to be used for research purposes. All methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki/GCP), as dictated by NHS-X.Regarding Fig. InternalRef removed, this is a screenshot of what the digital solution looked like, and ownership of the photo belongs to Huma Therapeutics whom have given full approval for image use. The people one can see in the image are not participants of this or any study.
: Not Applicable.
: Shah SS, Obika D and Valentine S were all employed by Huma Therapeutics, the vendor of the digital solution, during the pilot study. Their roles were clinical project management, tasked at implementing the clinical needs of the NHS primary care group lead by Safa A and Johal K.